Yoshiaki Sota

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Topics

Locally Advanced

Positive Breast Cancer

Gas Chromatography

Top Venues

Breast cancer (Tokyo, Japan)

This page only lists publications with an associated author ORCID identifier.

Publications

Sae Kitano, Ryo Tsunashima, Chikage Kato, Akira Watanabe, Yoshiaki Sota, Saya Matsumoto, Midori Morita, Koichi Sakaguchi, Yasuto Naoi
Validation of late recurrence prediction by gene expression profiles and clinicopathological factors in estrogen receptor-positive breast cancer. Breast cancer (Tokyo, Japan) (2024)
Akira Watanabe, Ryo Tsunashima, Chikage Kato, Sae Kitano, Saya Matsumoto, Yoshiaki Sota, Midori Morita, Koichi Sakaguchi, Yasuto Naoi
Investigation of recurrence prediction ability of EndoPredict ® using microarray data from fresh frozen tissues in ER-positive, HER2-negative breast cancer and indication expansion of EndoPredict ® from microarray data from fresh-frozen to FFPE tissues. Breast cancer (Tokyo, Japan) 31 (4) (2024)
Tomonori Tanei, Shigeto Seno, Yoshiaki Sota, Takaaki Hatano, Yuri Kitahara, Kaori Abe, Nanae Masunaga, Masami Tsukabe, Tetsuhiro Yoshinami, Tomohiro Miyake, Masafumi Shimoda, Hideo Matsuda, Kenzo Shimazu
High HER2 Intratumoral Heterogeneity Is a Predictive Factor for Poor Prognosis in Early-Stage and Locally Advanced HER2-Positive Breast Cancer. Cancers 16 (5) (2024)
Akira Watanabe, Ryo Tsunashima, Chikage Kato, Sae Kitano, Saya Matsumoto, Yoshiaki Sota, Midori Morita, Koichi Sakaguchi, Yasuto Naoi
Investigation of recurrence prediction ability of EndoPredict ® using microarray data from fresh frozen tissues in ER-positive, HER2-negative breast cancer and indication expansion of EndoPredict ® from microarray data from fresh-frozen to FFPE tissues. Breast cancer (Tokyo, Japan) (2024)
Sae Kitano, Ryo Tsunashima, Chikage Kato, Akira Watanabe, Yoshiaki Sota, Saya Matsumoto, Midori Morita, Koichi Sakaguchi, Yasuto Naoi
Validation of late recurrence prediction by gene expression profiles and clinicopathological factors in estrogen receptor-positive breast cancer. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Akira Watanabe, Ryo Tsunashima, Chikage Kato, Sae Kitano, Saya Matsumoto, Yoshiaki Sota, Midori Morita, Koichi Sakaguchi, Yasuto Naoi
Investigation of recurrence prediction ability of EndoPredict ® using microarray data from fresh frozen tissues in ER-positive, HER2-negative breast cancer and indication expansion of EndoPredict ® from microarray data from fresh-frozen to FFPE tissues. Breast cancer (Tokyo, Japan) 31 (4) (2024)
Tomonori Tanei, Shigeto Seno, Yoshiaki Sota, Takaaki Hatano, Yuri Kitahara, Kaori Abe, Nanae Masunaga, Masami Tsukabe, Tetsuhiro Yoshinami, Tomohiro Miyake, Masafumi Shimoda, Hideo Matsuda, Kenzo Shimazu
High HER2 Intratumoral Heterogeneity Is a Predictive Factor for Poor Prognosis in Early-Stage and Locally Advanced HER2-Positive Breast Cancer. Cancers 16 (5) (2024)
Yoko Hashimoto, Nanae Masunaga, Naofumi Kagara, Kaori Abe, Tetsuhiro Yoshinami, Masami Tsukabe, Yoshiaki Sota, Tomohiro Miyake, Tomonori Tanei, Masafumi Shimoda, Kenzo Shimazu
Detection of Ultra-Rare ESR1 Mutations in Primary Breast Cancer Using LNA-Clamp ddPCR. Cancers 15 (9) (2023)
Yoko Hashimoto, Nanae Masunaga, Naofumi Kagara, Kaori Abe, Tetsuhiro Yoshinami, Masami Tsukabe, Yoshiaki Sota, Tomohiro Miyake, Tomonori Tanei, Masafumi Shimoda, Kenzo Shimazu
Detection of Ultra-Rare ESR1 Mutations in Primary Breast Cancer Using LNA-Clamp ddPCR. Cancers 15 (9) (2023)